According to the United States Patent and Trademark Office, more than 3,420,560 US patents were granted to tracked assignees between 2015 and 2025. This guide explains how to read that data on PlainPatent; every figure we publish is computed directly from the public USPTO PatentsView dataset, and our methodology documents how each is derived and verified. Last reviewed June 2026.

What Patent Portfolios Reveal About Company Strategy

Every patent a company files is a strategic decision. Where they patent reveals what they are building. How many claims they write reveals how seriously they intend to defend it. And how their filing velocity changes over time reveals where they are accelerating — or retreating.

Reading a Patent Portfolio Like a Strategist

A patent portfolio is not just a count of patents. It is a multi-dimensional map of a company's innovation investments. The key dimensions are:

1. Technology Concentration vs. Diversification

Some companies concentrate patents in a narrow set of technology classes — this signals deep expertise in a specific domain. Others spread patents across many classes — signaling diversified R&D or a platform play. Neither is inherently better, but the pattern tells you about strategic intent.

Example: Qualcomm's portfolio is heavily concentrated in wireless communication (H04) — reflecting their core business as a wireless IP licensor. Apple's portfolio spans computing (G06), display technology (G09), wearable devices (A61), and audio — reflecting their consumer electronics platform strategy.

2. Filing Velocity and Trajectory

Year-over-year patent filing trends reveal strategic pivots in near-real-time — often 2–3 years before product announcements. A company that suddenly doubles its AI patent filings is making a strategic bet on AI, regardless of what their press releases say.

Conversely, declining filing velocity in a technology area can signal a strategic retreat — the company may be winding down R&D in that domain, selling the business unit, or shifting resources elsewhere.

3. Claim Depth and Defensive Intent

Companies filing patents with many detailed claims (20–40+ per patent) are building defensive walls. They intend to make it difficult for competitors to design around their IP. Companies filing with minimal claims (5–10) may be building a portfolio for portfolio size or cross-licensing leverage rather than active enforcement.

Pharmaceutical patents often have the highest claim counts — each claim variant covers a different formulation, dosage, or delivery mechanism, creating overlapping protection that is extremely difficult to challenge.

4. Geographic Filing Patterns

While PlainPatent focuses on US patents, the decision to file in the US at all is strategic. Companies prioritize filing in markets where they sell products and where enforcement is effective. A foreign company that files heavily in the US is signaling their intent to compete in the American market.

Portfolio Patterns by Industry

Technology (Google, Microsoft, Apple)

Broad portfolios spanning software, hardware, AI, and cloud. High volume, moderate claim depth. Used primarily for cross-licensing and defensive positioning. Filing velocity correlates with strategic initiatives (cloud, AI, devices).

Semiconductors (Intel, TSMC, Samsung)

Deep portfolios concentrated in fabrication, chip design, and packaging. High claim depth — semiconductor patents are expensive to work around. Filing velocity tracks process node advancement (5nm, 3nm, 2nm).

Pharmaceuticals (Pfizer, J&J, Roche)

Smaller volume but highest claim depth. Each patent is a high-value asset protecting billions in drug revenue. Filing is tightly tied to the drug pipeline — a surge in filings often precedes clinical trial results or regulatory submissions.

Automotive (Toyota, Ford, GM)

Portfolios are diversifying rapidly from traditional mechanical engineering into EV batteries, autonomous driving, and connectivity. Companies whose portfolios show a sharp shift toward H01M (batteries) and G06N (AI) are signaling a serious EV and autonomy commitment.

Strategic Signals to Watch

When analyzing a company's portfolio on PlainPatent, look for these patterns:

  • New technology classes appearing: When a company starts filing in a technology area it has never patented in before, it is entering a new market or building a new capability. This is one of the earliest detectable strategic signals.
  • Velocity spikes in specific classes: A sharp increase in filings within one technology area signals increased investment. Track this on individual company profiles.
  • Declining velocity with stable revenue: A company that stops patenting while maintaining revenue may be harvesting existing IP rather than investing in new R&D — a potential warning for long-term competitiveness.
  • Claim depth increases: When a company starts filing more detailed, higher-claim-count patents, they are taking IP defense more seriously — possibly in response to competitive threats or in preparation for licensing programs.
  • Cross-class convergence: Companies filing at the intersection of traditionally separate classes (e.g., computing + medical, automotive + telecom) are building platform capabilities that span industries.

Practical Applications

Patent portfolio analysis is used across several professional domains:

  • Competitive intelligence: Identify what your competitors are working on before they announce it
  • Investment research: Evaluate whether a company's innovation pipeline supports its growth narrative
  • M&A due diligence: Assess the IP strength and technology fit of acquisition targets
  • Technology scouting: Find companies leading in specific technology areas through technology class exploration
  • Partnership evaluation: Understand a potential partner's technology capabilities and strategic direction
Data source: USPTO PatentsView — US granted patents 2015–2025. Company-level portfolio analysis uses disambiguated assignee data. CPC codes from the Cooperative Patent Classification system.

Frequently Asked Questions

Can I use patent data to predict what a company is building?

Patent filings offer strong directional signals about R&D focus, typically 2–5 years ahead of product launches. However, not all patents result in products — some are defensive, some are exploratory. The strongest signal comes from sustained filing velocity in a technology area, not individual patents.

How do I compare two companies' patent portfolios?

On PlainPatent, look at each company's profile to compare total volume, technology breadth (CPC class distribution), claim depth, filing velocity, and Innovation Score. Companies competing in the same market with very different portfolio profiles often have fundamentally different competitive strategies.

What does it mean when a company sells its patents?

Patent sales or portfolio divestitures typically signal a strategic retreat from a technology area. The buyer is either building competitive IP, planning a licensing program, or acquiring defensive coverage. High-profile patent sales (like Nortel's portfolio sale to a Google/Apple/Microsoft consortium) can reshape competitive dynamics in entire industries.

Are patent filings a reliable measure of innovation?

Patent filings measure inventive output that companies consider worth legally protecting. They correlate with R&D spending and innovation activity but are not a complete measure. Some innovation is protected through trade secrets, some is open-sourced, and some is simply not patentable. Patent data is best used alongside other indicators like R&D budgets, publications, and product launches.

Data sourced from official public datasets, primarily the USPTO PatentsView database. See our methodology for details on how we calculate innovation scores.